We hypothesise that the similar proteomic landscape between ERα‐P and ERα‐C tumours could be due to activity of other steroid hormone receptors (SHRs), such as Androgen Receptor (AR), PR, or Glucocorticoid Receptor (GR), now compensating for loss of ERα action. This evidence concerns the gene NR3C1 and neoplasm.